Hoffman 3E Rollover Guide

Immunoglobulin G Subclass Deficiency Primary Immune Dysfunction: T- Cell Deficiencies

Chapter 19, page 360

Chapter 19, page 375

Chapter 19, page 361

Chapter 19, page 376

DiGeorge Syndrome

Chapter 19, page 361 Chapter 19, page 361 Chapter 19, page 361 Chapter 19, page 361 Chapter 19, page 362 Chapter 19, page 365

Chapter 19, page 376 Chapter 19, page 376 Chapter 19, page 376 Chapter 19, page 376 Chapter 19, page 377 Chapter 19, page 380

Epidemiology

Pathophysiology

Clinical Manifestations

Interprofessional Management Other T-Cell Immune Deficiencies

Chronic Mucocutaneous Candidiasis Hyper-IgM Syndrome

Chapter 19, page 365

Chapter 19, page 380

Chapter 19, page 365

Chapter 19, page 380

Primary Immune Deficiency of both T and B Cells Secondary Immune Dysfunction: Therapy-Induced Deficiencies

Chapter 19, page 365

Chapter 19, page 380

Chapter 19, page 366

Chapter 19, page 381

Epidemiology

Chapter 19, page 366 Chapter 19, page 366 Chapter 19, page 366 Chapter 19, page 367

Chapter 19, page 381 Chapter 19, page 381 Chapter 19, page 381 Chapter 19, page 382

Pathophysiology

Interprofessional Management Excessive Immune Response Type I Hypersensitivity Reaction: Immediate

Chapter 19, page 369

Chapter 19, page 384

Epidemiology

Chapter 19, page 369 Chapter 19, page 369 Chapter 19, page 369 Chapter 19, page 370

Chapter 19, page 384 Chapter 19, page 385 Chapter 19, page 385 Chapter 19, page 386

Pathophysiology

Clinical Manifestations

Interprofessional Management Type II Hypersensitivity Reaction: Cytotoxic

Chapter 19, page 373

Chapter 19, page 390

Epidemiology

Chapter 19, page 373

Chapter 19, page 390

Pathophysiology and Clinical Manifestations Interprofessional Management Type III Hypersensitivity Reaction: Immune Complex

Chapter 19, page 373

Chapter 19, page 390

Chapter 19, page 375

Chapter 19, page 392

Chapter 19, page 375

Chapter 19, page 392

Epidemiology

Chapter 19, page 375

Chapter 19, page 392

Pathophysiology and Clinical Manifestations Interprofessional Management Type IV Hypersensitivity Reactions

Chapter 19, page 375

Chapter 19, page 392

Chapter 19, page 375 Chapter 19, page 376 Chapter 19, page 376

Chapter 19, page 393 Chapter 19, page 393 Chapter 19, page 393

Epidemiology

Pathophysiology and Clinical Manifestations Interprofessional Management

Chapter 19, page 376

Chapter 19, page 393

Chapter 19, page 376

Chapter 19, page 393 Chapter 19, page 394

Type V Hypersensitivity: Stimulated Chapter 19, page 377

FADavis.com 13

Powered by